6.79 USD
▲+0.11+5.76%
盘后 6.42 0.00%
2026-08-03
市值
$369.51M
市盈率
—
EPS
-2.90
股息率
—
52 周区间
5.85 – 33.68
成交量
1.36M
Beta
—
目标价
38.25
52W 低 5.8552W 高 33.68
价格走势
公司简介
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.